Stroke treatment for unknown wake-up time
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a clot-busting drug for people who had a stroke but don't know when it started, like waking up with symptoms. It may help reduce disability if given soon after noticing symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had a stroke with symptoms you noticed within the last 3 hours, but the exact start time is unknown (like waking up with symptoms)
- Your stroke symptoms are moderate to severe, scoring 6 to 25 on a stroke severity scale
- You were independent before the stroke, able to do daily activities without help
- You have not had bleeding in the brain, recent major surgery, or active bleeding
- You are not pregnant or breastfeeding and meet other safety checks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called rhTNK-tPA for treating acute ischemic stroke (a clot in the brain) up to 24 hours after symptom onset. The study uses simplified imaging to determine eligibility and aims to help patients recover better outcomes.
This trial studies the use of a clot-busting medicine called tenecteplase given more than 4.5 hours after a stroke starts. It aims to see if this treatment can help people who wake up with stroke symptoms or whose stroke time is unknown.
This trial tests a clot-dissolving medicine called tenecteplase for people who had a stroke more than 4.5 hours ago. It may help you recover if given later than usual.
This trial tests a clot-busting drug called tenecteplase given later than usual (4.5 to 9 hours after stroke symptoms) to people whose MRI shows the stroke may still be reversible. The goal is to see if it helps reduce disability after a stroke.
This trial tests whether a clot-dissolving drug called tenecteplase can improve recovery for people who had a large-vessel ischemic stroke 4.5 to 24 hours earlier and can’t have a mechanical clot removal procedure in time. If you join, you’ll get either tenecteplase or standard medical care, and the study will track your recovery and safety.
This trial tests a clot-busting drug called tenecteplase given directly into the brain artery for people having a moderate stroke caused by a blockage in a medium-sized blood vessel. The goal is to see if it helps improve recovery when given within 24 hours of stroke symptoms starting.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.